The Recall Desk
Agency classClass IOur severity:CriticalFDA (Drugs)·D-0293-2024·Announced 2024-02-14

FDA recalls Rugby brand lubricating eye drops nationwide for non-sterility

Rugby brand Polyvinyl Alcohol 1.4% Lubricating Eye Drops are being recalled nationwide due to non-sterility. The recall affects all lots of the 0.5 FL OZ bottles distributed.

The agency’s classification

FDA (Drugs): Class I

Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 5/5 (Critical).

Highest-severity recall. The hazard can cause serious injury or death. Stop using the product now and follow the agency's instructions.

Our severity reasoning: This is an FDA Class I recall, which the rubric identifies as Critical severity. FDA Class I indicates a serious health hazard where non-compliance could cause or contribute to serious adverse health consequences. Non-sterile eye drops present a significant risk of ocular contamination and infection.

Plain-English summary

Rugby brand Polyvinyl Alcohol 1.4% Lubricating Eye Drops, packaged in 0.5 FL OZ (15 mL) bottles, are being recalled nationwide. The product is distributed by Rugby Laboratories in Livonia, Michigan, under National Drug Code (NDC) 0536-1325-94. Approximately 1,492,344 bottles with all lot numbers have been distributed.

The recall is due to non-sterility. Non-sterile eye drops may be contaminated and could cause serious eye infections.

The recall affects all lots distributed nationwide within the United States. Consumers should not use this product.

The recalled product

Product
Rugby brand Polyvinyl Alcohol 1.4% Lubricating Eye Drops, packaged in 0.5 FL OZ (15 mL) bottles, Distributed by: Rugby Laboratories, Livonia, MI 48152, NDC 0536-1325-94
Affected units
1,492,344

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All lots

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 22 recalled by Kilitch Healthcare India Limited under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 22 products in this recall →

Similar recalls